Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synvisc-One in Indian Patients with Knee Osteoarthritis
NCT02389452Phase 4Completed
- Sponsor
- Sanofi
- Start
- Feb 2010
- Primary completion
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of hylan gf-20 in knee osteoarthritis (OA), sponsored by Sanofi. Started Feb 2010; status: completed.
02
Drugs
hylan gf-20
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02389452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02389452.